Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Nanomedicine. 2017 Feb 28;13(5):1637–1644. doi: 10.1016/j.nano.2017.02.008

Table 1.

Rate constants for pharmacokinetic modeling of liposomal doxorubicin. The first order rate constants for modeling pharmacokinetic behavior of liposomal doxorubicin in mice. All values are in h−1. The elimination rate constant, kel, and the rate constants that describe movement between the vascular and peripheral compartments, kp and kd, are determined with fits to data obtained in tumor-free mice. These are then held constant to model data from LS 174T tumor-bearing mice to determine values for the rate constant to describe movement into the tumor compartment from the circulation and back, kepr and kb, respectively.

Rate Constant Tumor-free (s−1) LS 174T tumor (s−1)
kp 14.0
kd 19.9
kel 0.1 0.124
kepr 0.011
kb 0.022